OpenScholar

Search results

267 results found

Retraction Note: Selective killing of cancer cells by a small molecule targeting the stress response to ROS

Publication: Journal Article

Raj, L., T. Ide, A. U. Gurkar, M. Foley, M. Schenone, X. Li, N. J. Tolliday, et al. 2018. “Retraction Note: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS”. Nature 561: 420.

Multiclass cancer diagnosis using tumor gene expression signatures

Publication: Journal Article

Ramaswamy, S., P. Tamayo, R. Rifkin, S. Mukherjee, C. H. Yeang, M. Angelo, C. Ladd, et al. 2001. “Multiclass Cancer Diagnosis Using Tumor Gene Expression Signatures”. Proc Natl Acad Sci U S A 98: 15149-54.

The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K

Publication: Journal Article

Slabicki, M., Z. Kozicka, G. Petzold, Y. D. Li, M. Manojkumar, R. D. Bunker, K. A. Donovan, et al. 2020. “The CDK Inhibitor CR8 Acts As a Molecular Glue Degrader That Depletes Cyclin K”. Nature 585: 293-97.

Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling

Page

https://depmap.org/repurposing/

Rishi Puram

Person: Postdoctoral Fellow

I am a postdoctoral fellow in the Golub lab using functional genomics and chemical screening approaches to define mechanism of action of epigenetic therapy in hematologic malignancies.

Research

Page

Positions Available

Page

Current Openings: Thank you for your interest. Please keep an eye on this page for openings. We welcome inquiries from students and experienced scientists at all levels. Please send your inquiries to TRGapplications@broadinstitute.org, and please be sure to include what position you are interested...